Next-Generation Excipients: Driving Sustainable Innovation in Oral Drug Delivery

Sustainability is rapidly becoming a defining factor in pharmaceutical innovation, requiring a shift from ambition to measurable action. This talk explores how sustainability can be embedded across the entire value chain of oral drug delivery—from excipient design to application phase. Evonik will highlight the importance of setting clear targets, using Life Cycle Assessment (LCA) as a data-driven decision tool, and proactively aligning with emerging regulatory frameworks. We will focus particularly on the development of a biodegradable polymer platform that combines high functional performance with reduced environmental impact. Attendees will gain insights into how integrating sustainability into excipient design and portfolio strategy can create a competitive advantage while ensuring compliance, innovation, efficacy and long-term value for both patients and industry.